Okuroglu N, Ozturk A, Özdemir A
University of Health Sciences, "Fatih Sultan Mehmet" Training and Research Hospital, Istanbul, Turkey.
Acta Endocrinol (Buchar). 2020 Jan-Mar;16(1):49-52. doi: 10.4183/aeb.2020.49.
The first trimester of pregnancy is the most sensitive period in terms of thyroid hypofunction. Iron deficiency has been associated with both thyroid function and thyroid autoimmunity.
We aimed to investigate whether iron deficiency is a risk factor for thyroid autoimmunity in non-pregnant women at childbearing age.
This cross- sectional study was conducted in non-pregnant women who presented to the Internal Medicine Policlinic between January 2018 and December 2018 in the University of Health Sciences "Fatih Sultan Mehmet" Training and Research Hospital.
Three hundred fifty-eight non-pregnant women of reproductive ages (203 iron deficient-ID, 155 control) participated in this study. Women with known thyroid disease, currently undergoing treatment for thyroid disease or whose thyroid function tests were outside the reference range were excluded from the study. Blood sample was taken after at least 8-10 hours of fasting for measurement of serum iron (Fe), total iron binding capacity (TIBC), serum ferritin (SF), whole blood count, thyroid function tests (fT4, TSH), anti-thyroid peroxidase antibodies (TPOAb) and anti-thyroglobulin antibody (TgAb). The patients with SF levels ≤ 15 ng/dL were accepted as iron deficiency.
The group with ID had higher TSH and lower T4 values that did not reach statistical significance compared to the control group (p=0.101 and p=0.098, respectively). Antibody positivity was more frequent in the ID group than in the control group (35.96% 20.65%, p = 0.002).
Iron deficiency is associated with thyroid autoimmunity and it should be considered as a risk factor for screening thyroid antibody, particularly in pregnancy planning women.
就甲状腺功能减退而言,妊娠早期是最敏感的时期。缺铁与甲状腺功能及甲状腺自身免疫均有关联。
我们旨在调查缺铁是否为育龄非妊娠女性甲状腺自身免疫的危险因素。
这项横断面研究在健康科学大学“法提赫苏丹穆罕默德”培训与研究医院2018年1月至2018年12月期间到内科门诊就诊的非妊娠女性中开展。
358名育龄非妊娠女性(203名缺铁女性,155名对照)参与了本研究。已知患有甲状腺疾病、目前正在接受甲状腺疾病治疗或甲状腺功能测试结果超出参考范围的女性被排除在研究之外。在至少禁食8 - 10小时后采集血样,以测定血清铁(Fe)、总铁结合力(TIBC)、血清铁蛋白(SF)、全血细胞计数、甲状腺功能测试(游离甲状腺素(fT4)、促甲状腺激素(TSH))、抗甲状腺过氧化物酶抗体(TPOAb)和抗甲状腺球蛋白抗体(TgAb)。血清铁蛋白水平≤15 ng/dL的患者被认定为缺铁。
与对照组相比,缺铁组的促甲状腺激素水平较高,甲状腺素水平较低,但差异无统计学意义(分别为p = 0.101和p = 0.098)。缺铁组的抗体阳性率高于对照组(35.96%对20.65%,p = 0.002)。
缺铁与甲状腺自身免疫相关,应将其视为甲状腺抗体筛查的危险因素,尤其是在计划妊娠的女性中。